CFTR modulator therapies – Effect on life expectancy in people with cystic fibrosis
- 1 June 2022
- journal article
- research article
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 42, 3-8
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot studyPediatric Diabetes, 2013
- Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United StatesJNCI: Journal of the National Cancer Institute, 2012
- Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosisEuropean Respiratory Journal, 2011
- Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosisThorax, 2011
- Changing epidemiology and clinical issues arising in an ageing cystic fibrosis populationTherapeutic Advances in Respiratory Disease, 2010
- Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpointJournal of Cystic Fibrosis, 2010
- Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcomeHepatology, 2002
- Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcomeHepatology, 2002
- The Prognostic Value of Exercise Testing in Patients with Cystic FibrosisNew England Journal of Medicine, 1992